U.S. Chamber COVID-19 Vaccines FAQ

As you know, the U.S. Food and Drug Administration (FDA) recently granted emergency use authorization for COVID-19 vaccines developed by Pfizer and Moderna. As states begin to prioritize, allocate, and distribute the first doses, the U.S. Chamber has created a new COVID-19 Vaccines FAQ one-pager to answer the common questions being asked by Americans—and especially business leaders.

Click here to view the one-pager with accurate and current information about the vaccine allocation process, expected timelines, and what it all means for the road to recovery.

The U.S. Chamber will continue to update this resource as new information becomes available.